Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,884,328
  • Shares Outstanding, K 52,183
  • Annual Sales, $ 136,190 K
  • Annual Income, $ -105,900 K
  • EBIT $ -106 M
  • EBITDA $ -103 M
  • 60-Month Beta 1.01
  • Price/Sales 36.19
  • Price/Cash Flow N/A
  • Price/Book 20.43

Options Overview Details

View History
  • Implied Volatility 53.51% ( -0.35%)
  • Historical Volatility 92.39%
  • IV Percentile 27%
  • IV Rank 8.93%
  • IV High 147.70% on 07/29/24
  • IV Low 44.28% on 05/24/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 193
  • Volume Avg (30-Day) 1,440
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 8,834
  • Open Int (30-Day) 14,759

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.34
  • Number of Estimates 7
  • High Estimate -0.29
  • Low Estimate -0.40
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +37.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.54 +40.67%
on 10/23/24
103.81 -9.84%
on 11/11/24
+25.49 (+37.42%)
since 10/22/24
3-Month
66.54 +40.67%
on 10/23/24
103.81 -9.84%
on 11/11/24
+13.33 (+16.61%)
since 08/22/24
52-Week
33.45 +179.82%
on 11/28/23
103.81 -9.84%
on 11/11/24
+58.90 (+169.74%)
since 11/22/23

Most Recent Stories

More News
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PRCT : 93.60 (-0.90%)
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

PRCT : 93.60 (-0.90%)
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

PRCT : 93.60 (-0.90%)
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

PRCT : 93.60 (-0.90%)
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

PRCT : 93.60 (-0.90%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

AVAI : 0.5000 (-5.66%)
MYO : 5.09 (+6.04%)
PRCT : 93.60 (-0.90%)
ISRG : 547.87 (-0.50%)
ABSI : 2.56 (+0.39%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”)...

PRCT : 93.60 (-0.90%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”)...

PRCT : 93.60 (-0.90%)
Why Shares of Procept Biorobotics Were Slumping Thursday

The company released first-quarter earnings on Thursday morning.

PRCT : 93.60 (-0.90%)
PROCEPT BioRobotics Corporation (PRCT) Q2 2022 Earnings Call Transcript

PRCT earnings call for the period ending June 30, 2022.

PRCT : 93.60 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 97.21
2nd Resistance Point 96.21
1st Resistance Point 94.90
Last Price 93.60
1st Support Level 92.59
2nd Support Level 91.59
3rd Support Level 90.28

See More

52-Week High 103.81
Last Price 93.60
Fibonacci 61.8% 76.93
Fibonacci 50% 68.63
Fibonacci 38.2% 60.33
52-Week Low 33.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar